Collaborating to Compete: Blood Profiling Atlas in Cancer (BloodPAC) Consortium-Reference-Cited by-同舟云学术

Collaborating to Compete: Blood Profiling Atlas in Cancer (BloodPAC) Consortium

Published:2017-04-12 Issue:5 Volume:101 Page:589-592
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin. Pharmacol. Ther.

Author:

Grossman RL¹,Abel B²,Angiuoli S³,Barrett JC⁴,Bassett D⁵,Bramlett K⁶,Blumenthal GM⁷,Carlsson A⁸,Cortese R⁹,DiGiovanna J⁹,Davis-Dusenbery B⁹,Dittamore R¹⁰,Eberhard DA²,Febbo P²,Fitzsimons M¹,Flamig Z¹,Godsey J¹¹,Goswami J¹²,Gruen A⁹,Ortuño F¹,Han J²,Hayes D¹³,Hicks J⁸,Holloway D⁹,Hovelson D¹³,Johnson J⁴,Juhl H¹⁴,Kalamegham R¹⁵,Kamal R¹⁶,Kang Q¹³,Kelloff GJ¹⁷,Klozenbuecher M¹⁶,Kolatkar A⁸,Kuhn P⁸,Langone K²,Leary R¹⁸,Loverso P³,Manmathan H⁹,Martin A-M¹⁹,Martini J²⁰,Miller D¹,Mitchell M²¹,Morgan T¹³,Mulpuri R²²,Nguyen T¹,Otto G²³,Pathak A²⁴,Peters E²⁵,Philip R²⁴,Posadas E²⁶²⁷,Reese D²²,Reese MG¹⁶,Robinson D¹⁸,Dei Rossi A²,Sakul H²⁰,Schageman J⁶,Singh S²³,Scher HI²¹,Schmitt K¹,Silvestro A¹⁸,Simmons J³,Simmons T¹,Sislow J¹,Talasaz A²⁸,Tang P¹,Tewari M¹³,Tomlins S¹³,Toukhy H²⁸,Tseng HR²⁶²⁹,Tuck M¹³,Tzou A²⁴,Vinson J²¹,Wang Y¹⁰,Wells W³⁰,Welsh A²³,Wilbanks J³¹,Wolf J²²,Young L²³,Lee JSH¹⁷,Leiman LC³²

Affiliation:

1. Center for Data Intensive Science; University of Chicago; Chicago Illinois USA

2. Genomic Health; Redwood City California USA

3. Personal Genome Diagnostics; Baltimore Maryland USA

4. AstraZeneca; Waltham Massachusetts USA

5. Celgene; Seattle Washington USA

6. Thermo Fisher Scientific; Austin Texas USA

7. Center for Drug Evaluation and Research; Food and Drug Administration; Silver Springs Maryland USA

8. Department of Molecular and Medical Pharmacology; Crump Institute for Molecular Imaging, University of California; Los Angeles California USA

9. Seven Bridges; Cambridge Massachusetts USA

10. Epic Research and Diagnostics; San Diego California USA

11. Thermo Fisher Scientific; Waltham Massachusetts USA

12. Thermo Fisher Scientific; Carlsbad California USA

13. University of Michigan; Ann Arbor Michigan USA

14. Indivumed GmbH; Hamburg Germany

15. Genentech; Washington District of Columbia USA

16. Omicia; Oakland California USA

17. Office of the Director; National Cancer Institute; Bethesda Maryland USA

18. Novartis Institute for Biomedical Research; Cambridge Massachusetts USA

19. Novartis Pharmaceuticals; East Hanover New Jersey USA

20. Pfizer; San Diego California USA

21. Memorial Sloan Kettering Cancer Center; New York New York USA

22. Provista Diagnostics Inc.; New York New York USA

23. Foundation Medicine; Cambridge Massachusetts USA

24. Center for Device and Radiological Health; Food and Drug Administration; Silver Springs Maryland USA

25. Genentech; South San Francisco California USA

26. CytoLumina, Inc.; Los Angeles California USA

27. Cedar-Sinai Medical Center; Los Angeles California USA

28. Guardant Health, Inc.; Redwood City California USA

29. Crump Institute for Molecular Imaging; University of California; Los Angeles California USA

30. Open Commons Consortium; Chicago Illinois USA

31. Sage Bionetworks; Seattle Washington USA

32. BloodPAC; Chicago Illinois USA

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Reference7 articles.

1. White House (US) Remarks by the President in State of the Union Address [Internet] https://obamawhitehouse.archives.gov/the-press-office/2015/01/20/remarks-president-state-union-address-january-20-2015 2015

2. cobas EGFR Mutation Test v2, June 2, 2016 2016 http://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm504540.htm

3. List of Cleared or Approved Companion Diagnostic Devices (In Vitro and Imaging Tools) 2016 http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/InVitroDiagnostics/ucm301431.htm

4. Considerations in the development of circulating tumor cell technology for clinical use;Parkinson;J. Transl. Med.,2012

5. Evidence of clinical utility: an unmet need in molecular diagnostics for patients with cancer;Parkinson;Clin. Cancer Res.,2014

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lexicon for blood‐based early detection and screening: BLOODPAC consensus document;Clinical and Translational Science;2024-08-29

2. Liquid Biopsy Profiling with Multiple Tests in Patients with Metastatic Breast Cancer;Journal of Molecular Pathology;2024-05-09

3. Subpar reporting of pre‐analytical variables in RNA‐focused blood plasma studies;Molecular Oncology;2024-04-02

4. A Case for Accelerating Standards to Achieve the FAIR Principles of Environmental Health Research Experimental Data;Environmental Health Perspectives;2023-06

5. Standard Operating Procedures (SOPs) for non-invasive multiple biomarkers detection in an academic setting: A critical review of the literature for the RENOVATE study protocol;Critical Reviews in Oncology/Hematology;2023-05